Loya Capital📈

Final Verdict — Behari Lal Engineering IPO :- - This is a small but solid engineering company. It makes metal rolls, castings, and alloy steel parts for steel, mining, and auto sectors. - Margins are improving well. EBITDA margin rose from 13.67% to 18.97% over three years. This shows better cost control and product mix. - Profit grew faster than sales. PAT rose 22% while revenue rose only 6%. This means growth is coming more from efficiency, not from big new orders yet. - Price looks fair, even cheap. P/E is around 18.6-18.7x, well below the peer average of ~31x. This gives real valuation comfort, not just hype. - ROE and ROCE are strong. ROE at 23.6% beats peer average of 9.5%. ROCE is 27.11%. This shows the company uses its capital well. - Big risk: most of the issue is OFS. Out of ₹302 Cr, only ₹93 Cr is fresh money for the company. The rest goes to existing shareholders. - Customer risk exists too. Around 85% of revenue comes from repeat customers, but some customer churn is seen among newer ones. - Business depends a lot on the auto sector. Any slowdown there can hit demand. There is also some unhedged forex exposure. - GMP is strong, around ₹53-68, showing near 20-24% expected listing gain. Subscription demand is healthy too, above 2x. • Overall: fair price, strong margins, and decent listing gain expectation make this a reasonable pick. But slow revenue growth and heavy OFS mean this is more a valuation-comfort story than a big growth story. Good for both listing gain and a measured long-term hold.

Final Verdict on Milky Mist Dairy Food IPO:- - Milky Mist shows real growth. Revenue grew 34% in FY26, to ₹3,138 Cr, and the shift from low-margin milk to high-margin products like paneer and cheese is working. - Profit jumped 176%, from ₹46 Cr (FY25) to ₹127 Cr (FY26). But part of this jump — about 19% — came from a one-time tax credit, not from the core business.If you remove that tax credit, profit growth was still strong at 122%. But net margin is only around 4%, which is thin. Even after big revenue growth, actual profit stays small in size. - Because of this, real P/E is higher than it looks. On paper it's 85x FY26 earnings, but without the tax credit boost, it works out closer to 105x. This means the market is paying a lot for a small and partly one-time profit number.Price is very high overall — P/B is around 28.5x too. This shows investors are betting heavily on future growth, not on current profit strength. - Debt is a big concern. Total borrowings are ₹1,671.85 Cr. IPO money will repay part of this, but debt stays high even after that. - Business depends too much on one region — nearly 70% of sales and 95%+ of raw milk supply come from Tamil Nadu. Any local problem can hit the whole business. - Sector mood is weak too. Every listed dairy peer (Hatsun, Dodla, Heritage, Parag) is down in 2026 due to rising milk costs. Overall: good long-term story, but you're paying a high price today for profit growth that isn't fully proven yet. Not a safe, cheap entry point. Very High Risk Taking Investors can consider for very small listing gains seeing subscription Figures specially QIB response tomorrow i.e. on Final Day.

Final Verdict on Molbio Diagnostics IPO:- - Strong niche business with its own diagnostic platform (Truenat), used in 90+ countries with real pricing power. - Revenue grew fast at 42%, but profit grew slower at 18%. Margin needs watching. - Most of the issue money (79%) goes to old shareholders, not the company. Only ₹200 Cr comes to the business for R&D. - Price is high at 56.67x P/E. This is priced for future growth, not a cheap buy. - GMP is moderate, around 15-18%. Subscription is decent. -Good pick for long-term hold in the healthcare space with continued Margins Watch. Listing gains looks steady, not a Jackpot. So Risk Taking Investors can consider for small listing gains.

*Dhoot Transmission IPO — Final Review* - Market leader with 41% share in 2W/3W wiring harness, and about 70% share in electric 2W/3W. This is a direct play on India's EV growth. - Revenue grew 31% in FY26 to ₹4,525 Cr. Profit grew too, to ₹396.84 Cr, up 12% YoY. - Margin is under pressure. EBITDA margin fell from 18.31% in FY24 to 15.71% in FY26, due to rising copper cost. - Price looks fair at 44.9x P/E, lower than peers like Uno Minda (56.87x) and Sona BLW (74.64x). - Big risk: no fixed order book. Business runs on regular OEM orders, with no volume guarantee. - Customer risk is high — Bajaj, TVS, and Hero together make up about 60% of revenue. - GMP is strong, around ₹259-270, showing near 30% expected listing gain. *-Verdict: Good for both listing gain and long term hold, but keep an eye on customer concentration after listing.*

Final Verdict on Ardee Industries IPO ( Mainboard ) :- - Ardee Industries shows strong, real growth — revenue up 57% and profit up 155% in FY26, backed by rising demand for recycled lead in EV and battery sectors. - Valuation is fair on P/E (~19.70x) for this growth pace, though P/B is high at 21.54, so some future growth is already priced in. - About ₹106 Cr from the issue is OFS, going to old shareholders, not the company. - Main risk is commodity price swing — lead and scrap prices move fast and can hit margins. - GMP has moved up strongly to ₹14-15, showing ~26-28% expected listing gain, with healthy subscription (15x overall, NII 31x+). - Overall, Can be considered from both decent listing gains and long-term hold.

Final Verdict on MV Electrosystems IPO (MAINBOARD) :- - Strong Railway ties, big order book (₹921.64 Cr, ~19x FY26 revenue). - FY26 turned into a loss, after profit in FY25. - Cash flow went deep negative due to high inventory build-up. - Can't judge valuation on current earnings; peer comparison is weak. - Too much dependent on one customer, Indian Railways, - Risky bet on future execution — okay for listing gain, not yet safe for long term. Overall bit risk taking investors can consider for 15-20%.

Final Review on Manipal Health Enterprises IPO :- This is a large, well-known hospital brand with real scale, but the Valuation Offered is very High and profit trend is weak right now. A large part of the fresh issue money goes to repay debt at the hospital subsidiary, not to build new capacity. Weak GMP and soft subscription both point to a flat or muted listing. Good brand, poor entry price — better to wait and watch than rush in. *AVOID !*

INDO-MIM IPO UPDATE

Gold Trading Just Got Smarter, Cheaper, and Fully Legal! 📈✨ Why pay high brokerage fees when you can trade Gold legally on an FIU-registered platform in India? 🔥 Why Choose Delta Exchange India? FIU Registered: Fully compliant with Government of India regulations. Unbeatable Fees: Ultra-low trading fees at just 0.001%. High Liquidity & Fast Execution: Trade smoothly without high overhead costs. Trade Gold the right way. Pure compliance, minimal fees, maximum potential. 💰 👉 Sign up today & start trading: https://www.delta.exchange/?code=LOYACAPITAL

NIFTY SHORT SETUP. HIGH RISK TRADE

CALIBER MINING & LOGISTICS IPO - MAINBOARD

INDO-MIM IPO UPDATE

CALIBER MINING & LOGISTICS IPO - MAINBOARD

Update on Kusumgar Ltd IPO - Mainboard :- Consider Applying from Good listing gains perspective. Note :- Tomorrow is the last day to apply

Aaj NFP news Hai @ 6PM !

literally i want to sell below this candle but RR is getting spoiled